Grant B, Katon W, Beitman B
J Fam Pract. 1983 Nov;17(5):907-14.
Panic disorder is a subtype of anxiety manifested by discrete periods of apprehension or fear and at least four of the following somatic symptoms: dyspnea, palpitations, chest pain, choking, dizziness, depersonalization or derealization experience, paresthesias, hot and cold flashes, sweating, faintness, trembling, and fear of dying, going crazy, or doing something uncontrolled during an attack. Because the patient with panic disorder often selectively focuses on one of these somatic symptoms and may minimize or deny psychosocial distress, panic disorder is frequently misdiagnosed. As a result of the frightening nature of the symptoms, a pattern of overutilization of medical care systems frequently ensues. Panic disorder is usually precipitated by stressful life events, most commonly separation or loss, in a patient with a genetic or acquired vulnerability. As with other psychophysiologic illness (depression, duodenal ulcer) resolution of the acute stressful life event may not lead to resolutions of the physiologic changes. Two specific tricyclic antidepressants, imipramine and desipramine, have been shown to be effective therapeutic agents in treating panic disorder.
惊恐障碍是焦虑症的一种亚型,表现为间歇性的忧虑或恐惧,并伴有至少以下四种躯体症状:呼吸困难、心悸、胸痛、窒息感、头晕、人格解体或现实解体体验、感觉异常、潮热或寒战、出汗、眩晕、颤抖,以及在发作期间害怕死亡、发疯或做出不受控制的行为。由于惊恐障碍患者常常选择性地关注其中一种躯体症状,可能会淡化或否认心理社会困扰,因此惊恐障碍常常被误诊。由于这些症状的可怕性质,常常会出现过度利用医疗保健系统的模式。惊恐障碍通常由应激性生活事件引发,最常见的是分离或丧失,发生在具有遗传或后天易感性的患者身上。与其他心理生理疾病(抑郁症、十二指肠溃疡)一样,急性应激性生活事件的解决可能不会导致生理变化的解决。两种特定的三环类抗抑郁药,即丙咪嗪和地昔帕明,已被证明是治疗惊恐障碍的有效治疗药物。